EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

D-alanylation of lipoteichoic acids inhibitor provides anti-virulence and anti-resistance effects against methicillin-resistant Staphylococcus epidermidis

Alexandre Mahé iD, Nicolas Verneuil, Delphine Coupri, Axel Hartke, Vincent Cattoir iD, Isabelle Rincé, Sabrina Gueulle, Xiao Feng, Thierry Lequeux, Emmanuel Pfund, Aurélie Budin-Verneuil iD

Antimicrobial Agents and Chemotherapy · 07.05.2025 · 69 (5)

DOI: 10.1128/aac.01822-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 07.05.2025. Verfasst von Alexandre Mahé und 10 weiteren Autor:innen. Beteiligte Einrichtung: CBSA UR 4312, Université de Caen Normandie, Caen, Normandy, France. Hauptthemen laut MEDLINE: Teichoic Acids, Staphylococcus epidermidis, Anti-Bacterial Agents, Lipopolysaccharides. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methicillin-resistant Staphylococcus epidermidis (MRSE) is an emerging multidrug-resistant pathogen responsible for numerous healthcare-associated infections. Most of them are resistant to all classes of antibiotics and thus lead to therapeutic impasse. For this reason, identifying new targets and characterizing new drugs are essential. We recently showed that methicillin-resistant Staphylococcus aureus strains deficient in D-alanylation of teichoic acids (TAs) lost resistance to various β-lactams. Here we explore if D-alanylation of TAs might be a druggable target to overcome β-lactam resistance of MRSE using a competitive DltA inhibitor. The binding affinity of a DltA inhibitor with the purified DltA protein was monitored by determining the half maximal inhibitory concentration (IC 50 ). The efficiency of D-alanylation inhibition was determined by quantifying the ester-linked D-alanine content of purified TAs. Minimal inhibition concentrations (MICs) and bactericidal effects of several β-lactams were monitored in the absence or presence of the inhibitor against a panel of clinical MRSE isolates. Finally, the ability of inhibition of D-alanylation (i) to rescue MRSE-infected larvae of Galleria mellonella and (ii) to prevent or eradicate S. epidermidis biofilms was evaluated. The DltA inhibitor showed IC 50 in the low µM range, drastically reduced the D-alanine esters content of TAs and re-sensitized MRSE to β-lactams. The most effective treatment was the DltA inhibitor/imipenem combination. Finally, inhibition of D-alanylation significantly reduced the virulence of MRSE in the G. mellonella infection model and strongly reduced the ability of S. epidermidis to form biofilms. All together, our results show the promising nature of the D-alanylation of TAs as a therapeutic target to fight against MRSE infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Teichoic AcidsStaphylococcus epidermidisAnti-Bacterial AgentsLipopolysaccharidesMicrobial Sensitivity TestsAnimalsVirulencebeta-LactamsBiofilmsMothsMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAlanineLarva

Stichwörter der Autor:innen

D-alanylationD-alanylation inhibitionStaphylococcus epidermidisadjuvantanti-biofilmanti-virulenceantibiotic resistancebeta-lactamsmethicillin-resistanceteichoic acids

Substanzen

Teichoic AcidsAnti-Bacterial Agentslipoteichoic acidLipopolysaccharidesbeta-LactamsAlanine

Autor:innen und Institutionen

  • CBSA UR 4312, Université de Caen Normandie, Caen, Normandy, France.
  • Department of Clinical Microbiology and National Reference Center for Enterococci, University Hospital of Rennes, Rennes, Brittany, France.
  • INSERM Unit U1230, University of Rennes, Rennes, Brittany, France.
  • Laboratoire de Chimie Moléculaire et Thioorganique LCMT UMR 6507, ENSICAEN, UNICAEN, CNRS, Normandie Université, Caen, Normandy, France.

ORCID-Profile: Alexandre Mahé, Vincent Cattoir, Aurélie Budin-Verneuil

Förderung

  • Agence Nationale de la Recherche

Zitieren

APA

Mahé, A., Verneuil, N., Coupri, D., Hartke, A., Cattoir, V., Rincé, I., Gueulle, S., Feng, X., Lequeux, T., Pfund, E., & Budin-Verneuil, A. (2025). D-alanylation of lipoteichoic acids inhibitor provides anti-virulence and anti-resistance effects against methicillin-resistant Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy, 69(5). https://doi.org/10.1128/aac.01822-24

Vancouver

Mahé A, Verneuil N, Coupri D, Hartke A, Cattoir V, Rincé I, et al. D-alanylation of lipoteichoic acids inhibitor provides anti-virulence and anti-resistance effects against methicillin-resistant Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy. 2025;69(5). doi:10.1128/aac.01822-24

BibTeX
@article{Mah2025,
  author = {Mahé, Alexandre and Verneuil, Nicolas and Coupri, Delphine and Hartke, Axel and Cattoir, Vincent and Rincé, Isabelle and Gueulle, Sabrina and Feng, Xiao and Lequeux, Thierry and Pfund, Emmanuel and Budin-Verneuil, Aurélie},
  title = {D-alanylation of lipoteichoic acids inhibitor provides anti-virulence and anti-resistance effects against methicillin-resistant Staphylococcus epidermidis},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  volume = {69},
  number = {5},
  doi = {10.1128/aac.01822-24}
}
Kostenlos starten →